Literature DB >> 15067149

Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002.

Thomas Delate1, Alan J Gelenberg, Valarie A Simmons, Brenda R Motheral.   

Abstract

OBJECTIVE: The aim of this study was to estimate the prevalence of use of prescription antidepressants among children and adolescents by using nationwide data and to examine trends in use from 1998 to 2002.
METHODS: Ambulatory prescription claims data for a nationwide random sample of more than 1.9 million life-years of commercially insured children (aged 18 years or younger) for the years 1998, 1999, 2000, 2001, and 2002 were examined retrospectively. The main outcome measure was trend in prevalence of antidepressant use.
RESULTS: The overall prevalence of antidepressant use among children increased from 160 per 10000 (1.6 percent) in 1998 to 240 per 10000 (2.4 percent) in 2002, for an adjusted annual increase of 9.2 percent. The growth in the overall prevalence of antidepressant use was greater among girls (a 68 percent increase) than boys (a 34 percent increase). In 2002, antidepressant use was highest among girls aged 15 to 18 years, at 640 per 10000 (6.4 percent). The trend of increasing overall use of antidepressants among children and adolescents appears to have been driven primarily by greater use of selective serotonin reuptake inhibitors.
CONCLUSIONS: The growth in the prevalence of use of antidepressant medications among youths appears to be continuing, and the rate of increase between 1998 and 2002 is similar to the rate of increase seen in the period of the second-generation antidepressants (late 1980s to mid-1990s).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067149     DOI: 10.1176/appi.ps.55.4.387

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  18 in total

Review 1.  Treating depression in children and adolescents: what options now?

Authors:  Christopher K Varley
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys.

Authors:  Chadi A Calarge; Bridget Zimmerman; Diqiong Xie; Samuel Kuperman; Janet A Schlechte
Journal:  J Clin Psychiatry       Date:  2010-03       Impact factor: 4.384

Review 3.  Risk of adverse behavioral effects with pediatric use of antidepressants.

Authors:  Wayne K Goodman; Tanya K Murphy; Eric A Storch
Journal:  Psychopharmacology (Berl)       Date:  2006-12-19       Impact factor: 4.530

4.  Use of psychotropic medications in Italian children and adolescents.

Authors:  Antonio Clavenna; Elisa Rossi; Marisa Derosa; Maurizio Bonati
Journal:  Eur J Pediatr       Date:  2006-10-07       Impact factor: 3.183

5.  Outside the Black Box: Re-assessing Pediatric Antidepressant Prescription.

Authors:  Jacqueline A Sparks; Barry L Duncan
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2013-08

6.  Generalizing from clinical trial data: a case study. The risk of suicidality among pediatric antidepressant users.

Authors:  Joel B Greenhouse; Eloise E Kaizar; Kelly Kelleher; Howard Seltman; William Gardner
Journal:  Stat Med       Date:  2008-05-20       Impact factor: 2.373

7.  Correlates and psychiatric disorders associated with psychotropic drug use in Taiwan.

Authors:  I-Chia Chien; Shin-Huey Bih; Ching-Heng Lin; Yiing-Jenq Chou; Wen-Guang Lee; Cheng-Hua Lee; Pesus Chou
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-11-20       Impact factor: 4.328

8.  Cognitive Behavioral Therapy in Primary Care for Youth Declining Antidepressants: A Randomized Trial.

Authors:  Gregory Clarke; Lynn L DeBar; John A Pearson; John F Dickerson; Frances L Lynch; Christina M Gullion; Michael C Leo
Journal:  Pediatrics       Date:  2016-05       Impact factor: 7.124

9.  Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics.

Authors:  Chadi A Calarge; Vicki L Ellingrod; Bridget Zimmerman; Michael M Bliziotes; Janet A Schlechte
Journal:  J Clin Psychiatry       Date:  2011-12       Impact factor: 4.384

10.  Cost-effectiveness of Cognitive Behavioral Therapy for Depressed Youth Declining Antidepressants.

Authors:  John F Dickerson; Frances L Lynch; Michael C Leo; Lynn L DeBar; John Pearson; Gregory N Clarke
Journal:  Pediatrics       Date:  2018-01-19       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.